Mahito Fukui
Direktor/Vorstandsmitglied bei C&O Pharmaceutical Technology (Holdings) Ltd.
Profil
Mahito Fukui is currently an Executive Director at C&O Pharmaceutical Technology (Holdings) Ltd.
He completed his undergraduate and graduate degrees at Kwansei Gakuin University in 1995 and 1997 respectively.
He also obtained an MBA from Aoyama Gakuin University in 2005.
Aktive Positionen von Mahito Fukui
Unternehmen | Position | Beginn |
---|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | 01.03.2019 |
Ausbildung von Mahito Fukui
Kwansei Gakuin University | Undergraduate Degree |
Aoyama Gakuin University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Health Technology |